| Trial ID: | L3831 |
| Source ID: | NCT00530881
|
| Associated Drug: |
Phx1149
|
| Title: |
Randomized, Double-Blind, Placebo-Controlled, With PHX1149 in Patients With Type 2 Diabetes Mellitus
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: PHX1149
|
| Outcome Measures: |
Primary: postprandial blood glucose | Secondary: fasting blood glucose, HbA1c, safety
|
| Sponsor/Collaborators: |
Sponsor: Phenomix
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
180
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2006-04
|
| Completion Date: |
2006-10
|
| Results First Posted: |
|
| Last Update Posted: |
2007-09-18
|
| Locations: |
Multiple Sites, san Diego, California, 92121, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00530881
|
